PeerVoice is an independent, professional medical publishing concern focused on gathering and reporting information pertaining to clinically relevant advances and developments in the science and practice of medicine. As publishers of PeerVoice Publications, PeerVoice is solely responsible for the selection of publication topics, the preparation of editorial content and the distribution of all materials it publishes.
http://www.peervoice.com
Gesamtlänge aller Episoden: 4 days 13 hours 29 minutes
Addressing the Triple Challenge of Myelofibrosis: Symptoms, Splenomegaly, and Cytopenias
Addressing the Triple Challenge of Myelofibrosis: Symptoms, Splenomegaly, and Cytopenias
Practical Guidance for Identifying and Managing Patients With Advanced MET Exon 14-Skipping NSCLC
Practical Guidance for Identifying and Managing Patients With Advanced MET Exon 14-Skipping NSCLC
Insights on the Increasing Impact of Emerging Therapies in NSCLC: Highlights From Spring 2022
Insights on the Increasing Impact of Emerging Therapies in NSCLC: Highlights From Spring 2022
Managing the Nuances of Paroxysmal Nocturnal Haemoglobinuria: Practical Strategies for Patients Receiving Complement Inhibitors
Managing the Nuances of Paroxysmal Nocturnal Haemoglobinuria: Practical Strategies for Patients Receiving Complement Inhibitors
Managing Thrombosis in Cancer: A Double Debacle and Then Add COVID
Managing Thrombosis in Cancer: A Double Debacle and Then Add COVID
Personalising Management of Advanced RCC: How I Treat
Personalising Management of Advanced RCC: How I Treat
‘B’ Vigilant: HCC Surveillance Protocols in Patients With Chronic Hepatitis B
‘B’ Vigilant: HCC Surveillance Protocols in Patients With Chronic Hepatitis B
Immunotherapeutic Approaches in the Treatment of Relapsed/Refractory Acute Lymphoblastic Leukemia: Insights From the Real World
Immunotherapeutic Approaches in the Treatment of Relapsed/Refractory Acute Lymphoblastic Leukemia: Insights From the Real World
A Clinical Conversation on Metastatic Hormone-Sensitive Prostate Cancer: Intensifying Therapy Earlier in the Disease Course
A Clinical Conversation on Metastatic Hormone-Sensitive Prostate Cancer: Intensifying Therapy Earlier in the Disease Course